Another study found that the concurrent administration of Akkermansia and Prevotella copri in germ-free mice significantly potentiated anti-PD-1 therapy effectiveness against metastatic melanoma, NSCLC, and RCC 170. This evidence concerns the gene PDCD1 and renal cell carcinoma.